Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/176864
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Echarri, Ana | - |
dc.contributor.author | Vera, Isabel | - |
dc.contributor.author | Ollero, Virginia | - |
dc.contributor.author | Arajol, Claudia | - |
dc.contributor.author | Riestra, Sabino | - |
dc.contributor.author | Robledo, Pilar | - |
dc.contributor.author | Calvo, Marta | - |
dc.contributor.author | Gallego, Francisco | - |
dc.contributor.author | Ceballos, Daniel | - |
dc.contributor.author | Castro, Beatriz | - |
dc.contributor.author | Aguas, Mariam | - |
dc.contributor.author | García López, Santiago | - |
dc.contributor.author | Marín Jiménez, Ignacio | - |
dc.contributor.author | Chaparro, María | - |
dc.contributor.author | Mesonero, Francisco | - |
dc.contributor.author | Guerra, Iván | - |
dc.contributor.author | Guardiola, Jordi | - |
dc.contributor.author | Nos, Pilar | - |
dc.contributor.author | Muñiz, Javier | - |
dc.contributor.author | MediCrohn study investigators | - |
dc.date.accessioned | 2021-04-28T15:28:23Z | - |
dc.date.available | 2021-04-28T15:28:23Z | - |
dc.date.issued | 2020-01-26 | - |
dc.identifier.issn | 1530-5627 | - |
dc.identifier.uri | http://hdl.handle.net/2445/176864 | - |
dc.description.abstract | Objectives: Mobile apps are useful tools in e-health and self-management strategies in disease monitoring. We evaluated the Harvey-Bradshaw index (HBI) mobile app self-administered by the patient to see if its results agreed with HBI in-clinic assessed by a physician. Methods: Patients were enrolled in a 4-month prospective study with clinical assessments at months 1 and 4. Patients completed mobile app HBI and within 48 h, HBI was performed by a physician (gold standard). HBI scores characterized Crohn's disease (CD) as remission <5 or active ≥5. We determined agreement per item and total HBI score and intraclass correlation coefficients (ICCs). Bland-Altman plot was performed. HBI changes in disease activity from month 1 to month 4 were determined. Results: A total of 219 patients were enrolled. All scheduled assessments (385 pairs of the HBI questionnaire) showed a high percentage of agreement for remission/activity (92.4%, κ = 0.796), positive predictive value (PPV) for remission of 98.2%, and negative predictive value of 76.7%. High agreement was also found at month 1 (93.15%, κ = 0.82) and month 4 (91.5%, κ = 0.75). Bland-Altman plot was more uniform when the HBI mean values were <5 (remission). ICC values were 0.82, 0.897, and 0.879 in all scheduled assessments, 1 and 4 months, respectively. Conclusions: We found a high percentage of agreement between patients' self-administered mobile app HBI and in-clinic physician assessment to detect CD activity with a remarkably high PPV for remission. The mobile app HBI might allow a strict control of inflammation by remote monitoring and flexible follow-up of CD patients. Reduction of sanitary costs could be possible. | - |
dc.format.extent | 9 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Mary Ann Liebert | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1089/tmj.2018.0264 | - |
dc.relation.ispartof | Telemedicine Journal and e-Health, 2020, vol. 26, num. 1, p. 78-86 | - |
dc.relation.uri | https://doi.org/10.1089/tmj.2018.0264 | - |
dc.rights | cc by (c) Echarri et al., 2019 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Aplicacions mòbils | - |
dc.subject.classification | Telecomunicació en medicina | - |
dc.subject.classification | Malaltia de Crohn | - |
dc.subject.other | Mobile apps | - |
dc.subject.other | Telecommunication in medicine | - |
dc.subject.other | Crohn's disease | - |
dc.title | The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 711855 | - |
dc.date.updated | 2021-04-28T15:28:24Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 30848700 | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
711855.pdf | 541.2 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License